Supply Chain

Here are the four latest drugs or medical devices approved by the Food and Drug Administration.  

The speculation around "Project Toto" began in 2014 when NorthPoint Development purchased a 67-acre plot of land in a Kansas City, Kansas-based industrial park. At the time, sources said an unspecified national retail chain planned to use the land for…

The Food and Drug Administration awarded $23 million in clinical trial research grants to research teams to encourage the development of treatments for patients with rare diseases.

Indianapolis-based drugmaker Eli Lilly earned accelerated approval from the Food and Drug Administration for a drug to treat adults with advanced soft tissue sarcoma, reports Reuters.

New Brunswick, N.J.-based Johnson & Johnson reported $17.8 billion in sales for the third quarter of 2016, a 4.2 percent increase from the same period last year.

NeoGrid, a Chicago-based provider of supply chain management solutions, partnered with the Brazilian startup Lett Insights to expand its offering of supply chain services.

Americans spent 7 percent more money on prescription drugs in 2016 than in 2015, presenting the largest increase since 1992, according to a report from the Bureau of Labor Statistics.

Johnson & Johnson Innovation will open a facility dedicated to expediting the development of "breakthrough" medical devices at Houston-based Texas Medical Center.

The Food and Drug Administration approved Roche's bladder cancer drug Tecentriq as a second-line treatment for patients with metastatic non-small cell lung cancer.

Bartlett (Tenn.) High School recently opened a Machine Tool Tech Lab on campus where students can learn how to use machinery to make medical devices, reports The Commercial Appeal.